Disease Management Clinical Decisions Hypogonadism is organized by Cleveland Clinic Center for Continuing Education.

Start Date: Oct 02, 2020
End Date: Oct 02, 2023

CME Accreditation:
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Description:
Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.

Objectives Topics:
After completing this case the reader should be able to:
• Select appropriate testing to evaluate patients with low serum testosterone.
• Determine whether the cause of male hypogonadism is primary (testicular) or secondary (hypothalamic/pituitary).
• Describe the differential diagnosis of male hypogonadism.
• Summarize the risks and benefits of testosterone replacement therapy.
• Review the various modes of testosterone replacement.